Is Darvocet (propoxyphene/acetaminophen) still available, and how should I safely discontinue it and select alternative analgesics?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Darvocet (Propoxyphene/Acetaminophen) Is No Longer Available

Darvocet and all propoxyphene-containing products were permanently withdrawn from the U.S. market in November 2010 due to fatal cardiac arrhythmias, and you should not attempt to obtain or use this medication. 1

Why Propoxyphene Was Removed

The FDA mandated withdrawal because propoxyphene causes:

  • Fatal cardiac toxicity including QTc prolongation and arrhythmias
  • Cardiotoxic effects from norpropoxyphene (a non-opioid metabolite)
  • Deaths that far outweighed any therapeutic benefit 2

Research consistently demonstrated that propoxyphene was no more effective than acetaminophen alone for pain relief, yet carried significant opioid-related risks including respiratory depression, addiction potential, and the cardiac dangers mentioned above 3, 2, 4.

Safe Discontinuation Strategy (If Somehow Still Taking)

If a patient is somehow still taking propoxyphene from old supplies, discontinuation must be gradual to prevent opioid withdrawal syndrome 1:

Tapering Protocol:

  • Reduce dose by 25-50% per day while monitoring for withdrawal symptoms 1
  • If withdrawal symptoms emerge (restlessness, anxiety, muscle aches, insomnia, GI distress, increased vital signs), increase back to previous dose and taper more slowly 1
  • Either increase the interval between dose reductions or decrease the amount of each reduction 1

Withdrawal symptoms to monitor: restlessness, lacrimation, rhinorrhea, yawning, perspiration, chills, myalgia, mydriasis, irritability, anxiety, backache, joint pain, weakness, abdominal cramps, insomnia, nausea, vomiting, diarrhea, elevated blood pressure/heart rate 1

Alternative Analgesic Selection

First-Line: Acetaminophen

Start with acetaminophen as first-line therapy for mild-to-moderate pain, particularly for osteoarthritis-related pain 4, 5:

  • Equally effective as propoxyphene was (and propoxyphene was no better than acetaminophen anyway)
  • Recommended by American College of Rheumatology as first-line for OA pain 4
  • Maximum dose: 4 grams daily (3 grams in elderly, malnourished, or liver disease patients) 5
  • Fast-dissolving formulations provide superior pain relief 5

Second-Line Options

Tramadol is the preferred next step for patients requiring more than acetaminophen but at risk for NSAID toxicity 4:

  • Effective for moderate pain
  • Lower risk profile than traditional opioids
  • Particularly useful in elderly patients who cannot tolerate NSAIDs

NSAIDs (use cautiously):

  • Consider only in younger patients without GI/renal/cardiovascular risk factors
  • Avoid in elderly due to GI bleeding, renal toxicity, and cardiovascular risks 4
  • If used, employ lowest effective dose for shortest duration

Other opioids (hydrocodone, oxycodone):

  • Reserve for severe pain unresponsive to non-opioid options
  • Following propoxyphene withdrawal, hydrocodone and tramadol were the most common substitutes 6
  • Must follow CDC 2022 opioid prescribing guidelines 7

If Prescribing Opioids

Per CDC 2022 guidelines, you must 7:

  • Set realistic expectations: complete pain elimination is unlikely; focus on functional improvement
  • Discuss serious risks: respiratory depression, opioid use disorder, death at higher doses
  • Warn about CNS depression with concurrent benzodiazepines, alcohol, or other sedatives
  • Prescribe naloxone for overdose reversal
  • Use PDMP monitoring and toxicology screening
  • Plan for periodic reassessment and potential tapering

Critical Pitfalls to Avoid

  1. Do not abruptly discontinue opioids in dependent patients - this precipitates withdrawal and increases risk of adverse events including seeking illicit opioids 8
  2. Do not exceed 4g daily acetaminophen - hepatotoxicity risk, especially when combining multiple acetaminophen-containing products 7, 1
  3. Do not assume propoxyphene was effective - it wasn't, so simpler alternatives like acetaminophen alone are appropriate 3, 2
  4. Avoid rapid tapers - research shows each additional week of taper time reduces adverse events by 7% 8

Real-World Context

After the 2010 withdrawal, 34% of propoxyphene users discontinued all opioids entirely, while most others transitioned to tramadol or hydrocodone 6. Importantly, adverse events did not increase after the withdrawal, supporting that propoxyphene provided minimal benefit 6. The prevalence of propoxyphene in workplace drug testing has appropriately declined to near-zero 9.

Related Questions

Why was Darvocet (propoxyphene and acetaminophen) discontinued?
What are the recommended intravenous and oral treatment regimens, including dosing, formulation, and duration, for muscular-type limb pain, and what alternatives should be used for patients with drug allergies?
What are the recommended intravenous and oral pharmacologic treatments, including dosage, formulation, duration, and allergy management, for an acute elbow sprain?
What is the recommended adult dose of paracetamol (acetaminophen) syrup?
In a 64-year-old man with severe right hip osteoarthritis, inadequate relief from acetaminophen, a history of peptic ulcer disease, atrial fibrillation treated with apixaban, hypertension, obesity, and the described physical exam findings, which of the following is the most appropriate next treatment: oxycodone as needed, intra‑articular hyaluronic acid, intra‑articular corticosteroid injection, or ibuprofen as needed?
For an adult with normal renal and hepatic function and no drug allergies, how should cefuroxime and ciprofloxacin be dosed together, and what safety monitoring is required?
How should persistent postoperative hiccups be managed in a patient six days after surgery who is afebrile?
What volume of azithromycin suspension (200 mg per 5 mL) should be administered to a 16‑kg child to achieve a dose of approximately 10 mg/kg?
How should I manage an escitalopram‑induced rise in prolactin levels?
What is the appropriate evaluation and management for an 8‑year‑old with a one‑month history of chronic headache and intermittent severe crying?
Does a positive Hepatitis A IgG (immunoglobulin G) result indicate that the individual is fit to work?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.